Knoll Capital Management, LLC Applied Therapeutics Inc. Transaction History
Knoll Capital Management, LLC
- $150 Million
- Q1 2025
A detailed history of Knoll Capital Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Knoll Capital Management, LLC holds 7,799,687 shares of APLT stock, worth $3.2 Million. This represents 2.55% of its overall portfolio holdings.
Number of Shares
7,799,687
Previous 5,799,687
34.48%
Holding current value
$3.2 Million
Previous $4.93 Million
22.48%
% of portfolio
2.55%
Previous 3.18%
Shares
15 transactions
Others Institutions Holding APLT
# of Institutions
94Shares Held
103MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.72 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.63 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.69 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.89MShares$2.41 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $19.7M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...